BridgeMD
New treatment option for ST-segment Elevation Myocardial Infarction
Official title The Thrombus Aspiration During PCI After Thrombolysis in STEMI
ClinicalTrials.gov ID: NCT06654453
What this study is testing
- What it's testing
- The goal of this clinical trial is to determine whether thrombus aspiration combined with percutaneous coronary intervention (PCI) improves clinical outcomes in ST-segment elevation myocardial infarction (STEMI) patients with high thrombus burden post-thrombolysis, compared to PCI alone. The study population includes 3500 STEMI patients, confirmed by diagnosis, who are transferred to PCI centers after receiving thrombolysis and have no contraindications to thrombolysis.The main questions it aims to answer are: 1.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Diagnosed with STEMI.
- No contraindications for thrombolysis and has received thrombolytic treatment.
- Undergoing coronary angiography within 2 to 24 hours post-thrombolysis.
- Angiographic results confirm TIMI thrombus load ≥ 4 and residual stenosis \> 50%.
You likely can't join if
- Contraindications for thrombolysis.
- Cardiogenic shock.
- Need for coronary artery bypass grafting.
- Age less than 18 years.
- Life expectancy of less than 6 months.
- Unable to provide informed consent.
The study team makes the final eligibility decision.
Where it's taking place
- Changsha, Hunan, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Changsha, Hunan, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.